Return To The Previous Page
Buy a Package
Number Of Visible Items Remaining : 3 Item

Changes in absolute lymphocyte count with teplizumab treatment

Changes in absolute lymphocyte count with teplizumab treatment
Total lymphocyte count fell by 72.3% (interquartile range [IQR] 82.1 to 68.4%) with a nadir on day 5. The lymphopenia resolved by day 45 in all but 1 participant who returned to normal on day 105.
From: Herold KC, Bundy BN, Long SA, et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med 2019; 381:603. Copyright © 2019 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.
Graphic 141624 Version 1.0

Do you want to add Medilib to your home screen?